chartexchange

BOLD
Boundless Bio, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
2.39USD-0.830%(-0.02)153,052
After-hoursNov 18, 2026 4:00:30 PM EST
2.40USD+0.418%(+0.01)
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
HQ
CA, USA
Previous Close
$2.41
Beta
-0.06
52-Week High
$3.16 2026-08-24
52-Week Low
$0.96 2026-02-05
SMA 50
$2.54
SMA 200
$1.99
Avg. Vol 10D
91,136
Avg. Vol 30D
142,282
Avg. Vol 90D
161,881
Relative Vol
1.08
18.17M
4.3000%
2,700,000
6,677
BOLD Profile

Audentes Therapeutics Inc is a biotechnology company. It is engaged in developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects.

BOLD Performance
PeriodPriceDateChangeBeta
1W2.462026-11-12-2.85%2.546
1M2.312026-10-19+3.46%0.384
3M2.862026-08-19-16.43%0.351
6M1.402026-05-19+70.71%-0.745
1Y1.152025-11-19+107.83%-0.060
2Y2.692024-11-19-11.15%—
5Y59.972020-01-14-96.02%0.930
BOLD Stock Summary

Boundless Bio, Inc. Common Stock (NASDAQ:BOLD) stock price today is $2.39, and today's volume is 153,052. BOLD is down 0.830% today. The 30 day average volume is 142,282. BOLD market cap is $56.43M with 23.61M shares outstanding.